Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-069173
Filing Date
2019-03-08
Accepted
2019-03-08 16:37:39
Documents
4
Effectiveness Date
2019-03-08

Document Format Files

Seq Description Document Type Size
1 S-8 d720187ds8.htm S-8 47904
2 EX-5.1 d720187dex51.htm EX-5.1 7431
3 EX-23.1 d720187dex231.htm EX-23.1 1585
4 GRAPHIC g720187g93o81.jpg GRAPHIC 3358
  Complete submission text file 0001193125-19-069173.txt   62675
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230164 | Film No.: 19669613
SIC: 2836 Biological Products, (No Diagnostic Substances)